Sự kết hợp Tuspetinib, Venetoclax và Azacitidine an toàn và hiệu quả trên nhiều nhóm phân tử ở bệnh nhân AML mới được chẩn đoán – OncLive
Tuspetinib Plus Venetoclax and Azacitidine Is Safe and Effective Across Molecular Subgroups in N…
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
文章相關商品
系統已根據文章標題、摘要和正文，自動匹配目前在售的強相關藥品。
維奈托克錠 VECLADX Venetoclax 100mg
維奈托克（Venetoclax，又譯為：維奈妥拉）是一種全世界首創的選擇性標靶b細胞淋巴瘤-2(BCL-2)蛋白的藥物。在某些血癌或其他癌症中，BCL-2起到了至關重要的作用，它可以阻止癌細胞的死亡（細胞凋亡），而維奈托克則是可以透過阻斷BCL-2蛋白來恢復凋亡過程。維奈托克旨在選擇性抑制BCL-2的功能，恢復細胞的通訊系統，讓癌細胞自我毀滅，達到治療腫瘤的目的。
查看商品
常見問題
Which products are related to this article?
The system matched these relevant products from the article content: 盧修斯 維奈托克 Venetoclax 線上購買、維奈托克錠 VECLADX Venetoclax 100mg.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
